[Neuromonitoring with S-100 protein in the intensive care unit].
During the last years biochemical neuromonitoring with various molecules such as S-100 protein has become popular. A huge number of investigations both experimental and clinical have been undertaken to determine diagnosis and prognosis of patients with acute neurologic diseases. This article gives a review on the current knowledge, indications and limitations on the use of S-100 protein with regard to most of the acute neurological diseases an intensivist is confronted with in everyday practice.
Fries
M
M
Klinik für Anästhesiologie, Universitätsklinikum Aachen. mfries@ukaachen.de
Bickenbach
J
J
Beckers
S
S
Henzler
D
D
Rossaint
R
R
Kuhlen
R
R
D001930:Brain Injuries / Q000097:blood / Q000503:physiopathology; D006348:Cardiac Surgical Procedures; D006259:Craniocerebral Trauma / Q000097:blood / Q000503:physiopathology; D003422:Critical Care; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods*; D009422:Nervous System Diseases / Q000175:diagnosis*; D009460:Neurologic Examination; D011379:Prognosis; D009418:S100 Proteins / Q000097:blood* / Q000378:metabolism
D009418:S100 Proteins